Trial Profile

An Open-label, Fixed-sequence, Drug-drug Interaction Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of JNJ-56136379 in Healthy Adult Participants

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 13 Dec 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bersacapavir (Primary) ; Itraconazole
Indications Hepatitis B
Focus Pharmacokinetics
Sponsors Janssen Sciences Ireland UC

Most Recent Events

01 Dec 2022 Results of pooled analysis from NCT03945539, NCT03111511 assessing Drug-Drug Interactions With the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379 published in the Clinical Pharmacology in Drug Development
26 Nov 2019 Status changed from active, no longer recruiting to completed.
01 Oct 2019 Planned End Date changed from 6 Oct 2019 to 4 Oct 2019.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com